Viewing Study NCT00361504

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:16 PM
Ignite Modification Date: 2026-05-19 @ 1:04 PM
Study NCT ID: NCT00361504
Status: COMPLETED
Last Update Posted: 2014-04-29
First Post: 2006-08-04
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: A Study to Evaluate Long-Term Safety of Multiple Doses of Tapentadol (CG5503) Prolonged-Release (PR) and Oxycodone Controlled-Release (CR) in Patients With Chronic Pain
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Osteoarthritis, Hip View
None Osteoarthritis, Knee View
None Lower Back Pain View
None Pain View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Osteoarthritis View
None Pain View
None Low Back Pain View
None Hip Pain View
None Knee Pain View
None Backache View
None Tapentadol View